drugset / Trial / NCT05375994
Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients
Non-randomizedSequentialOpen-labelTreatment
Summary
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with adagrasib in patients with G12C Non-Small Cell Lung Cancer (NSCLC) who have been exposed to prior G12C inhibitor and experienced progressive disease.
Timeline
- Start
- 2022-08-01
- Primary completion
- 2026-06-15
- Completion
- 2026-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adagrasib | Small molecule | — | — |
| Subject | Avutometinib | Small molecule | — | — |